Abstract
Background
The Niemann–Pick C1 (NPC1) protein regulates the transport of cholesterol from late endosomes/lysosomes to other compartments responsible for maintaining intracellular cholesterol homeostasis. Liver X receptors (LXRs) operate as cholesterol sensors which may protect from cholesterol overload by increasing the amount of free cholesterol in the plasma membrane through inducing NPC1 expression. NO-1886 has been proven to be highly effective at increasing liver X receptor α expression and promoting cellular cholesterol efflux. In this study, the effects of NO-1886 on NPC1 expression were investigated in THP-1 macrophage-derived foam cells.
Methods and results
Results showed that NO-1886 markedly increased expression of NPC1 at both mRNA level and protein level in a dose-dependent and time-dependent manner. Cellular cholesterol content was decreased while cholesterol efflux was increased by NO-1886 treatment. In addition, LXR α was also up-regulated by NO-1886 treatment. And LXR α small interfering RNA completely abolished the promotion effect which was induced by NO-1886.
Conclusion
These results provide evidence that NO-1886 up-regulates expression of NPC1 through LXR α pathway in THP-1 macrophage- derived foam cells.
Similar content being viewed by others
Abbreviations
- NPC1:
-
Niemann–Pick C1
- ABCA1:
-
ATP-binding cassette transporter A1
- LXR α :
-
liver X receptor α
- RCT:
-
reverse cholesterol transport
- HDL:
-
high density lipoprotein
- LPL:
-
lipoprotein lipase
References
Rubins HB, Robins SJ, Iwane MK, et al. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. Am J Cardiol. 1993;71:45–52.
Yokoyama S. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta. 2000;1529:231–44.
Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85:1343–72.
Vanier MT. Biochemical studies in Niemann–Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta. 1983;750:178–84.
Blanchette-Mackie EJ, Dwyer NK, Amende LM, et al. Type-C Niemann–Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc Natl Acad Sci USA. 1988;85:8022–6.
Goldin E, Roff CF, Miller SP, et al. Type C Niemann–Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Biochim Biophys Acta. 1992;1127:303–11.
Zervas M, Somers KL, Thrall MA, et al. Critical role for glycosphingolipids in Niemann–Pick disease type C. Curr Biol. 2001;11:1283–7.
Ory DS. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ Res. 2004;95:660–70.
Chawla A, Repa JJ, Evans RM, et al. Nuclear receptors and lipid physiology: opening the X-files. Science 2001;294:1866–70.
Zhang JR, Coleman T, Langmade SJ, et al. Niemann–Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J Clin Invest. 2008;118:2281–90.
Dai XY, Ou X, Hao XR, et al. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann–Pick type C1 in apoE−/− mice. J Cardiovasc Pharmacol. 2008;51:467–75.
Ou X, Dai XY, Long ZF, et al. Liver X receptor agonist T0901317 reduces atherosclerotic atherosclerotic lesions in apoE−/− mice by up-regulating NPC1 expression. Sci China Ser C-Life Sci. 2008;51:418–29.
Tsutsumi K, Inoue Y, Shima A, et al. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest. 1993;92:411–7.
Zhang C, Yin W, Liao D, et al. NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs. J Lipid Res. 2006;47:2055–63.
Ayaori M, Sawada S, Yonemura A, et al. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages. Arterioscler Thromb Vasc Biol. 2006;26:163–8.
Tang C, Wang Z, Yi G, et al. Effect of rolipram on ATP binding cassette transporter 1 and Cholesterol efflux in THP-1 macrophage-derived foam cell. Chin Pharmacol Bull. 2003;19:1177–82.
Wang N, Silver DL, Thiele C, et al. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276:23742–7.
Scott C, Ioannou YA. The NPC1 protein: structure implies function. Biochim Biophys Acta. 2004;1685:8–13.
Rigamonti E, Helin L, Lestavel S, et al. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res. 2005;97:682–9.
Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta. 2000;1529:164–74.
Garver WS, Heidenreich RA. The Niemann–Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system. Curr Mol Med. 2002;2:485–505.
Watari H, Blanchette-Mackie EJ, Dwyer NK, et al. Niemann–Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. Proc Natl Acad Sci USA. 1999;96:805–10.
Chen W, Sun Y, Welch C, et al. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem. 2001;276:43564–9.
Kusunoki M, Tsutsmi K, Inoue Y, et al. lipoprotein lipase activator NO-1886. Metabolism 2004;53:260–3.
Kusunoki M, Hara T, Tsutsmi K, et al. lipoprotein lipase activator NO-1886. Diabetologia 2000;43:875–80.
Yin W, Liao D, Kusunoki M, et al. NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine. J Endocrinol. 2004;180:399–408.
Yin W, Liao D, Wang Z, et al. NO-1886 inhibits size of adipocytes, suppresses plasma levels of tumor necrosis factor-alpha and free fatty acids, improves glucose metabolism in high-fat/high sucrose-fed miniature pigs. Pharmacol Res. 2004;49:199–206.
Scott C, Higgins ME, Davies JP, et al. Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain. J Biol Chem. 2004;279:48214–23.
Acknowledgment
The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (30470720), Post-doctor Sciences Foundation of China (2005037157), Hunan Provincial Natural Sciences Foundation of China (06jj5058) and The National Major Basic Research Program of China (973 Program) (grant no. 2006CB503808).
Author information
Authors and Affiliations
Corresponding author
Additional information
Xin Ma and Yan-Wei Hu contributed equally to this study.
Rights and permissions
About this article
Cite this article
Ma, X., Hu, YW., Mo, ZC. et al. NO-1886 Up-regulates Niemann–Pick C1 Protein (NPC1) Expression Through Liver X Receptor α Signaling Pathway in THP-1 Macrophage-Derived Foam Cells. Cardiovasc Drugs Ther 23, 199–206 (2009). https://doi.org/10.1007/s10557-009-6165-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-009-6165-8